benefits of microdosing glp 1 in menopause THE PCCA BLOG If you're in perimenopause or

These updates are not the same as full peer-reviewed publications, so treat them as preliminary until complete data are published

[DOI] [PubMed] [Google Scholar] (565).Yu W

Clinical data from GLP-1 trials show mean reductions in systolic blood pressure ranging from 2 to 5 mmHg, though individual variation is substantial

Importantly, as shown in the first row, LASSS supplementation effectively prevented an increase in the nitration level of ECM-HGF, whereas GSSSG did not demonstrate efficacy, inconsistent with its potent potential shown in in vitro experiments described earlier (see Figure 1b)

Indeed, clinical trials have reported significant spikes in GH even after a single injection of 10mcg/kg ipamorelin [11]